|
Volumn 41, Issue 5, 2003, Pages 491-492
|
Letters to the editor: Severe encephalopathy caused by intraparenchymal methotrexate instillation due to the design of the catheter [1]
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
METHOTREXATE;
BRAIN DISEASE;
BRAIN TUMOR;
CANCER CHEMOTHERAPY;
CASE REPORT;
CATHETER;
CHOROID PLEXUS;
CLINICAL FEATURE;
DISEASE SEVERITY;
DRUG SAFETY;
HUMAN;
LETTER;
MALE;
MEDULLOBLASTOMA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
CATHETERIZATION;
EQUIPMENT;
HOSPITALIZATION;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
METHODOLOGY;
PRIMARY PREVENTION;
RISK ASSESSMENT;
TOXICITY AND INTOXICATION;
BRAIN NEOPLASMS;
CATHETERIZATION;
CHILD, PRESCHOOL;
EQUIPMENT FAILURE;
HUMANS;
INJECTIONS, INTRAVENTRICULAR;
MAGNETIC RESONANCE IMAGING;
MALE;
MEDULLOBLASTOMA;
METHOTREXATE;
NEUROTOXICITY SYNDROMES;
PRIMARY PREVENTION;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
|
EID: 0642309911
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/mpo.10117 Document Type: Letter |
Times cited : (4)
|
References (4)
|